Heart--Hypertrophy En

Fiche du sujet

Référentiel
Identifiant

Synonyme

Heart enlargement Myocardial hypertrophy Cardiomegaly Heart--Hypertrophy and dilatation Cardiac hypertrophy Heart--Enlargement Enlargement of the heart Hypertrophic cardiomyopathy

Discipline

Economies et finances (3) Psychologie (2) Histoire (2) Histoire, Philosophie et Sociologie des sciences (2) Gestion et management (2) Architecture, aménagement de l'espace (2) Archéologie et Préhistoire (2)

Type de document

Articles (25) Recensions (3) Livres et chapitres d'ouvrages (2) Autres (1)

Auteur

Date

28 documents
Le titre du document n'a pas été fourni à ISIDORE, pour consulter le document, cliquez ici
(1 déc. 2023)
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
C. Fumagalli et al. (15 juin 2023)
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy.
N. Maurizi et al. (6 avr. 2023)
Genetically determined cardiomyopathies at autopsy: the pivotal role of the pathologist in establishing the diagnosis and guiding family screening.
M.N. Sheppard et al.
Sudden cardiac death in the young: A consensus statement on recommended practices for cardiac examination by pathologists from the Society for Cardiovascular Pathology.
K.L. Kelly et al. (2023)
The «Amish» NM_000256.3:c.3330+2T>G splice variant in MYBPC3 associated with hypertrophic cardiomyopathy is an ancient Swiss mutation.
C. Redin et al.
Le titre du document n'a pas été fourni à ISIDORE, pour consulter le document, cliquez ici
(21 janv. 2022)
Cardiac hypertrophy at autopsy.
C. Basso et al.
Molécules chaperons : exemple de la maladie de Fabry [Chaperone molecules: The example of Fabry disease]
F. Barbey et al.
Hypertrophie ventriculaire gauche isolée : et si c’était une maladie de Fabry ? [Isolated left ventricular hypertrophy : is it a Fabry disease?]
F. Barbey et al. (7 oct. 2020)
Inhibition of the Hypoxia-Inducible Factor 1α-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.
P. Mirtschink et al. (11 juin 2019)
Long-term impact of maternal high-fat diet on offspring cardiac health: role of micro-RNA biogenesis.
B. Siddeek et al. (2019)
RNAseq analysis of heart tissue from mice treated with atenolol and isoproterenol reveals a reciprocal transcriptional response.
A. Prunotto et al. (2016)
Old hearts for modern investigations: CT and MR for archaeological human hearts remains
F. Z Mokrane et al. (2016)
Jagged1 intracellular domain-mediated inhibition of Notch1 signalling regulates cardiac homeostasis in the postnatal heart.
M. Metrich et al. (2015)
HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease.
P. Mirtschink et al. (2015)
The Notch pathway controls fibrotic and regenerative repair in the adult heart.
M. Nemir et al. (2014)
Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxia.
G. Milano et al. (2013)
The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart.
R. Windak et al. (2013)
A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death.
C.H. Teirlinck et al. (2012)
EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy.
Roman Schoenauer et al. (2011)
Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF.
Q. Wang et al. (2010)
Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry.
A. Wagner et al. (2009)
Control of the adaptive response of the heart to stress via the Notch1 receptor pathway.
A. Croquelois et al. (2008)
AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.
G.K. Carnegie et al. (2008)

next